“EVERLAST-A: A Phase 2a Study Design of ORKA-001, a Novel Half-Life Extended IL-23p19 Monoclonal Antibody for Plaque Psoriasis”. SKIN The Journal of Cutaneous Medicine 9, no. 6 (November 10, 2025): s633. Accessed May 1, 2026. https://skin.dermsquared.com/skin/article/view/3768.